Detalhe da pesquisa
1.
Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation.
Transfusion;
2024 Jun 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38847196
2.
Administration of teclistamab in four patients with multiple myeloma requiring hemodialysis.
J Oncol Pharm Pract;
: 10781552241242022, 2024 Apr 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38576408
3.
Clinical efficacy of retreatment of daratumumab-based therapy (D2) in daratumumab-refractory multiple myeloma.
Eur J Haematol;
110(6): 626-632, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36752328
4.
Incidence of breakthrough fungal infections on isavuconazole prophylaxis compared to posaconazole and voriconazole.
Transpl Infect Dis;
25(2): e14045, 2023 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36856447
5.
Neutralizing antibody responses against SARS-CoV-2 in patients with plasma cell disorders who are on active treatment after two doses of mRNA vaccination.
Eur J Haematol;
109(5): 458-464, 2022 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35810359
6.
Expanding oncology pharmacist teams: Justifying the return on investment.
J Oncol Pharm Pract;
28(6): 1381-1387, 2022 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35274995
7.
Carfilzomib, cyclophosphamide, and dexamethasone (KCd) for the treatment of triple-class relapsed/refractory multiple myeloma (RRMM).
Eur J Haematol;
107(6): 602-608, 2021 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34378251
8.
American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Cell Transplantation and Cellular Therapy Patients in the United States.
Biol Blood Marrow Transplant;
26(6): 1043-1049, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32305359
9.
Intraperitoneal paclitaxel and cisplatin compared with dose-dense paclitaxel and carboplatin for patients with stage III ovarian cancer.
J Oncol Pharm Pract;
26(7): 1566-1574, 2020 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31948348
10.
American Society for Blood and Marrow Transplantation Pharmacy Special Interest Group Survey on Chimeric Antigen Receptor T Cell Therapy Administrative, Logistic, and Toxicity Management Practices in the United States.
Biol Blood Marrow Transplant;
25(1): 26-33, 2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30266675
11.
Tolerability and outcome of once weekly liposomal amphotericin B for the prevention of invasive fungal infections in hematopoietic stem cell transplant patients with graft-versus-host disease.
J Oncol Pharm Pract;
22(2): 228-34, 2016 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25471252
12.
Managing Infection Complications in the Setting of Chimeric Antigen Receptor T cell (CAR-T) Therapy.
Clin Hematol Int;
6(2): 31-45, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38817309
13.
Outpatient CAR T-Cell Therapy as Standard of Care: Current Perspectives and Considerations.
Clin Hematol Int;
6(2): 11-20, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38817307
14.
TACTUM: Trends in Access to Cellular Therapies in Multiple Myeloma, Perspectives of Treating Versus Referring Physicians.
Transplant Cell Ther;
2024 May 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38763416
15.
Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy.
Blood Cancer J;
14(1): 90, 2024 May 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38821914
16.
Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience.
Transplant Cell Ther;
30(3): 308.e1-308.e13, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38151105
17.
Hematopoietic stem cell transplantation-associated thrombotic microangiopathy and the role of advanced practice providers and pharmacists.
Bone Marrow Transplant;
58(6): 625-634, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37059738
18.
The story of the development of generic lenalidomide: How one company thwarted the Hatch-Waxman Act to generate billions of dollars in revenue.
J Cancer Policy;
38: 100446, 2023 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37777010
19.
Daratumumab, pomalidomide, and dexamethasone (DPd) followed by high dose chemotherapy-Autologous Stem Cell Transplantation leads to superior outcomes when compared to DPd-alone for patients with Relapsed Refractory Multiple Myeloma.
Transplant Cell Ther;
29(4): 262.e1-262.e6, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36682468
20.
Outcomes of Penta-Refractory Multiple Myeloma Patients Treated with or without BCMA-Directed Therapy.
Cancers (Basel);
15(11)2023 May 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37296856